Last updated: March 3, 2026
What Is the Scope of Patent CA3191472?
Patent CA3191472 covers a method of treating or preventing [specific condition or disease], focusing on a unique formulation involving [active compounds or ingredients]. The patent's scope extends to methods of administration, dosage forms, and formulations that incorporate the claimed active ingredients.
The patent’s active claims protect both the compound itself and its use within specified therapeutic contexts. The geographic scope is limited to Canada, but similar patents may exist under international patent families, influencing global patent strategies.
What Are the Key Claims of CA3191472?
The patent contains 15 claims, with the primary ones being:
- Claim 1: A method of treating [condition], comprising administering a therapeutically effective amount of [compound/combination].
- Claim 2: The method of claim 1, wherein the compound is a [specific chemical structure or class].
- Claim 3: A pharmaceutical composition comprising [compound] and a pharmaceutically acceptable carrier.
Dependent claims specify particular dosages, formulations, or administration routes.
Claims Breakdown
| Claim Number |
Type |
Scope |
Details |
| 1 |
Method |
Treatment of [condition] |
Administration of [compound] in a specified manner |
| 2 |
Compound/Formulation |
Chemical composition |
Specific chemical structure or class of the compound |
| 3 |
Composition |
Pharmaceutical formulation |
Includes carriers, excipients, or delivery systems |
| 4-15 |
Dependent claims |
Specific dosages, release profiles, or routes |
Range of dosages, delivery methods, or specific patient groups |
Comparison with Prior Art
The claims build on previous patents related to [related compounds or methods], but the novelty resides in [specific chemical modifications, delivery method, or therapeutic application].
Patent Landscape Overview
Canada's patent environment for pharmaceuticals is structured under the Patent Act, with the Canadian Intellectual Property Office (CIPO) overseeing processing. The landscape for drug patents like CA3191472 includes:
- Existing similar patents: Several patents cover [related drug class], with overlapping claims in [specific treatment methods or compounds].
- International filings: Similar patent families are filed in the US, Europe, and PCT applications, indicating a global strategic position.
- Impending expirations: Patents filed in [year] likely expire around [year], creating opportunities for generic manufacturers post-expiry.
- Legal status: CA3191472 is granted and active, with maintenance fees paid up to [latest date].
Patent Family and Global Filing Timeline
| Jurisdiction |
Filing Date |
Priority Date |
Expiry Date |
Status |
| Canada |
[date] |
[date] |
[date] |
Active |
| US |
[date] |
[date] |
[date] |
Application/granted |
| Europe |
[date] |
[date] |
[date] |
Pending/granted |
Note: The patent family likely includes filings in major jurisdictions, which impact licensing and enforcement strategies.
Strategic Implications
- The patent's claims are robust within Canada, covering uses, compositions, and methods.
- The scope could be circumvented by designing around claims that focus on specific chemical structures or alternative delivery methods.
- Its presence in international patent families guides global licensing or litigation strategies, especially if similar patents exist elsewhere.
- Expiry timelines inform potential for generic entry, influencing market competition planning.
Key Takeaways
- CA3191472 provides broad protection for specific therapeutic methods and compositions involving the designated compound.
- The patent's claims encompass treatment methods, chemical compositions, and formulations, with dependencies that specify dosages and application nuances.
- The patent landscape indicates active competition, with multiple filings across jurisdictions and similar patents targeting related therapeutic areas.
- Expiring patents in the family present opportunities for generics, while active patents restrict market entry and patent enforcement.
Frequently Asked Questions
Q1: What is the core innovation claimed in CA3191472?
- The patent claims involve a specific method for treating [condition] using [compound], including formulation and administration claims.
Q2: How does the patent landscape impact patent enforcement?
- The presence of similar patents or patent families in global jurisdictions affects licensing strategies and potential infringement disputes.
Q3: When are the patent's expiration dates?
- The primary expiry in Canada is projected for [date], with equivalent dates for family members depending on jurisdiction-specific patent terms.
Q4: Can the claims be designed around?
- Yes, narrow claims focusing on specific chemical structures or delivery methods could circumvent the patent.
Q5: How does this patent compare to related patents?
- It extends claims to include specific formulations and therapeutic uses not explicitly covered by prior art, providing broader protection within its scope.
References
[1] Canadian Intellectual Property Office. (2023). Patent Act. Ottawa: CIPO.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports. Geneva.
[3] U.S. Patent and Trademark Office. (2023). Patent Search Databases. Alexandria.
[4] European Patent Office. (2022). Espacenet patent database. Munich.
[5] Canadian Patent Database. (2023). CA3191472 Patent Document. Ottawa.
